DiaMedica Therapeutics Inc.

Ownership Transactions Reported by 19 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	3	+2.42 M	100%	$2.50	+$6.05 M
Sells	0
Net	+3	+2.42 M	100%		+$6.05 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Thomas Von Koch	10%+ Owner	$13.8 M	+$3 M	+27.7%	Jun 28, 2024
Jan Stahlberg	10%+ Owner	$13.1 M	+$3 M	+29.8%	Jun 28, 2024
Richard Jacinto II	10%+ Owner	$12.8 M			Jun 23, 2023
David J. Wambeke	Chief Business Officer	$1.48 M	+$49.2 K	+3.45%	Jun 1, 2024
Randall Michael Giuffre	Director	$1.15 M			Jun 1, 2024
Richard D. Pilnik	Director	$780 K			Jun 1, 2024
Amy L. Burroughs	Director	$205 K			Jan 3, 2023
Dietrich John Pauls	President and CEO, Director	$192 K			Jun 1, 2024
James T. Parsons	Director	$168 K			Jun 1, 2024
Harry W. Alcorn Jr	SVP, Clinical Operations	$123 K			Sep 15, 2021
Charles Pauling Semba	Director	$110 K			Jun 1, 2024
Scott Kellen	CFO and Secretary	$90.4 K			Jun 1, 2024
Richard Kuntz	Director	$40 K			Jun 1, 2024
Dominic R. Cundari	Chief Commercial Officer	$7.84 K			Jun 1, 2024
Tanya Lewis	Director	$0			Jun 1, 2024
Julie VanOrsdel Daves	SVP Clinical Development Oper.				Jun 1, 2023
Kirsten L. Gruis	Chief Medical Officer				Jun 1, 2023
Masuoka K. Lorianne	Chief Medical Officer				Jan 22, 2024
Sydney A. Gilman	VP, Regulatory Affairs				Jul 28, 2021

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership